Skip to main content

Table 2 Comparison of baseline and end-of-follow-up parameters in patients with central retinal vein occlusion

From: Intravitreal dexamethasone implant versus triamcinolone acetonide for macular oedema of central retinal vein occlusion: quantifying efficacy and safety

 

Dexamethasone (n = 20)

Triamcinolone (n = 20)

Baseline

After

P

Baseline

After

P

BCVA (log MAR ± SD)

1.06 ± 0.13

0.637 ± 0.54

0.0179

0.99 ± 0.15

0.508 ± 0.45

0.0142

CMT (µm)

551 ± 17.16

237 ± 20.71

0.0050

547.5 ± 13.79

232.6 ± 18.54

0.0050

IOP (mmHg)

16.7 ± 1.16

17 ± 1.94

0.7083

16.1 ± 2.60

22.2 ± 4.93

0.0076

  1. BCVA best-corrected visual acuity, CMT central macular thickness, IOP intraocular pressure, NS not significant
Back to article page

International Journal of Retina and Vitreous

ISSN: 2056-9920

Contact us